INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

OVERBROOK MANAGEMENT CORP's Holding History (CIK: 0001269786)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 219,326 Value ($000) $200 Avg Close — Range —
Q4 2024
Shares 219,326 Value ($000) $608 Avg Close — Range —
Q3 2024
Shares 219,326 Value ($000) $1,147 Avg Close — Range —
Q2 2024
Shares 219,326 Value ($000) $978 Avg Close — Range —
Q1 2024
Shares 219,326 Value ($000) $1,680 Avg Close — Range —
Q4 2023
Shares 219,326 Value ($000) $934 Avg Close — Range —
Q3 2023
Shares 219,326 Value ($000) $921 Avg Close — Range —
Q2 2023
Shares 219,326 Value ($000) $1,222 Avg Close — Range —
Q1 2023
Shares 219,326 Value ($000) $1,257 Avg Close — Range —
Q4 2022
Shares 219,326 Value ($000) $230 Avg Close — Range —
Q3 2022
Shares 69,326 Value ($000) $186 Avg Close — Range —
Q2 2022
Shares 69,326 Value ($000) $331 Avg Close — Range —
Q1 2022
Shares 16,726 Value ($000) $68 Avg Close — Range —
Q4 2021
Shares 16,726 Value ($000) $114 Avg Close — Range —
Q3 2021
Shares 16,726 Value ($000) $194 Avg Close — Range —
Q2 2021
Shares 16,726 Value ($000) $285 Avg Close — Range —
Q1 2021
Shares 16,726 Value ($000) $331 Avg Close — Range —
Q4 2020
Shares 16,726 Value ($000) $345 Avg Close — Range —
Q3 2020
Shares 16,726 Value ($000) $440 Avg Close — Range —